Evidence map›Paper›PMID 31246732›Full record

ArticlePain2019

The rostromedial tegmental nucleus: a key modulator of pain and opioid analgesia.

Norman E Taylor, Hu Long, JunZhu Pei, Phanidhar Kukutla, Anthony Phero, Farnaz Hadaegh, Ahmed Abdelnabi, Ken Solt, Gary J Brenner

Open access · greenAbstract read
In one paragraph

Article in Pain, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The rostromedial tegmental nucleus gates fat overconsumption through ventral tegmental area output in male rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Norman E TaylorDepartment of Anesthesiology, University of Utah, Salt Lake City, UT, United States.
Hu LongDepartment of Dentistry, West China Hospital of Stomatology, Sichuan University Chengdu, China.
JunZhu PeiDepartment of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, United States.
Phanidhar KukutlaDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States.
Anthony PheroDepartment of Anesthesiology, University of Utah, Salt Lake City, UT, United States.
Farnaz HadaeghDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States.
Ahmed AbdelnabiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States.
Ken SoltDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States.
Gary J BrennerDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, United States.
Massachusetts General Hospital · USUniversity of Utah · USMassachusetts Institute of Technology · US

Funding

Redesigning General Anesthesia (Admin Supp)R01GM104948 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BOYDEN, EDWARD S., BROWN, EMERY N · 2012 to 2016
$4.4M
Mechanisms of Caspase-1 Mediated Schwannoma RegressionR01NS081146 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BRENNER, GARY JAY · 2012 to 2016
$1.8M
Translation of AAV P0 ICE schwannoma gene therapy to clinical TrialsR21NS088013 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BRENNER, GARY JAY · 2015 to 2016
$846k
The Role of Periaqueductal Gray Dopamine Neurons in AnalgesiaK08GM121951 · NIGMS · UNIVERSITY OF UTAH · PI TAYLOR, NORMAN · 2017 to 2019
$482k
NIGMS NIH HHS K08 GM121951NIGMS NIH HHS R01 GM104948NINDS NIH HHS R01 NS081146NINDS NIH HHS R21 NS088013
6 · The paper itself

Abstract

A recently defined structure, the rostromedial tegmental nucleus (RMTg; aka tail of the ventral tegmental area [VTA]), has been proposed as an inhibitory control center for dopaminergic activity of the VTA. This region is composed of GABAergic cells that send afferent projections to the ventral midbrain and synapse onto dopaminergic cells in the VTA and substantia nigra. These cells exhibit µ-opioid receptor immunoreactivity, and in vivo, ex vivo, and optogenetic/electrophysiological approaches demonstrate that morphine excites dopamine neurons by targeting receptors on GABAergic neurons localized in the RMTg. This suggests that the RMTg may be a key modulator of opioid effects and a major brake regulating VTA dopamine systems. However, no study has directly manipulated RMTg GABAergic neurons in vivo and assessed the effect on nociception or opioid analgesia. In this study, multiplexing of GABAergic neurons in the RMTg was achieved using stimulatory Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) and inhibitory kappa-opioid receptor DREADDs (KORD). Our data show that locally infused RMTg morphine or selective RMTg GABAergic neuron inhibition produces 87% of the maximal antinociceptive effect of systemic morphine, and RMTg GABAergic neurons modulate dopamine release in the nucleus accumbens. In addition, chemoactivation of VTA dopamine neurons significantly reduced pain behaviors both in resting and facilitated pain states and reduced by 75% the dose of systemic morphine required to produce maximal antinociception. These results provide compelling evidence that RMTg GABAergic neurons are involved in processing of nociceptive information and are important mediators of opioid analgesia.

Indexed as

Analgesics, OpioidAnimalsDopaminergic NeuronsGABAergic Neuronsgamma-Aminobutyric AcidMice, TransgenicMorphineNeural PathwaysNucleus AccumbensReceptors, OpioidTegmentum MesencephaliVentral Tegmental AreaAnalgesics, Opioidgamma-Aminobutyric AcidMorphineReceptors, Opioid

Identifiers

PMID31246732
PMCPMC7343630
OpenAlexW2955870665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.